| Physostigmine Salicylate is a cholinesterase inhibitor with the potential to improve cognitive ability in individuals with alzheimers. In addition, as a parasympathomimetic, it is used to treat glaucoma, dry mouth, and delayed gastric emptying. Synonyms: 2-Hydroxybenzoic Acid compd. with (3aS,8aR)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate, , 2-Hydroxybenzoic acid, compd. with (3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1), Physostigmine Salicylate, Physostigmine Monosalicylate, (3aS,8aR)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-ol Methylcarbamate (Ester) Mono(2-hydroxybenzoate) (Salt), (3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-ol Methylcarbamate (Ester) Mono(2-hydroxybenzoate) (Salt), Salicylic Acid, compd. with aphysostigmine (1:1), (-)-Physostigmine salicylate, Eserine Salicylate, Isopto Eserine CAS No: 57-64-7 Free Base: 57-47-6 Molecular Formula: C15H21N3O2C7H6O3 Molecular Weight: 413.47 Appearance: White to pale brown solid Purity: 97% Melting Point: >175C (dec.) Solubility: DMSO (Slightly), Methanol (Slightly, Sonicated) Storage and Stability: May be stored at RT for short-term only. Long-term storage is recommended at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. |
